BioSpace News Archive

Business

Synlogic Reports Third Quarter 2017 Financial Results and Recent Progress

As of September 30, 2017, Synlogic had cash, cash equivalents, and short-term investments of $96.6 million.

November 13, 2017

·

9 min read

Business

Cellectis Reports Financial Results for Third Quarter and First Nine Months of 2017

As of September 30, 2017, Cellectis had $304.1 million in total cash, cash equivalents and current financial assets compared to $271.2 million as of June 30, 2017.

November 13, 2017

·

22 min read

Pharm Country

Effectiveness of ONC201 in H3 K27M Glioma to be Presented at SNO

Oncoceutics today announced that five clinical and preclinical presentations on ONC201 and ONC206 for the treatment of high grade gliomas will be presented at the 22nd Annual Scientific Meeting and Education Day of the Society of Neuro-Oncology, held November 16th-19th in San Francisco.

November 13, 2017

·

4 min read

Business

TapImmune to Provide Third Quarter 2017 Business Update Conference Call and Webcast

The event will be webcast live via the Internet on: November 15, 2017 4:30 p.m. ET

November 13, 2017

·

2 min read

Business

Pathogen Detection Leader Aperiomics Expands International Reach With Milenia Labs

Aperiomics, a biotech company that harnesses the power of deep next-generation sequencing to identify all known pathogens in a single test, today announced that it is partnering with Milenia Labs to further expand its international outreach.

November 13, 2017

·

2 min read

Business

Arcadia Biosciences Announces Passing of Board Chairman George Gosbee

Gosbee joined the Arcadia board in May 2015 and was appointed chair in November 2016.

November 13, 2017

·

1 min read

Policy

Argentum Pharma Succeeds in Starting Patent Cancellation Trial Against Valeant’s JUBLIA

Today, the U.S. Patent & Trademark Office granted Argentum Pharma’s petition for IPR against all patent claims in the first patent listed in the FDA’s Orange Book as covering Valeant’s JUBLIA. Argentum is challenging all claims of U.S. Patent No. 7,214,506.

November 13, 2017

·

1 min read

Genetown

Alnylam Pharmaceuticals Announces Proposed Public Offering of $675M of Common Stock

All of the shares in the offering are to be sold by Alnylam.

November 13, 2017

·

5 min read

Pharm Country

Cycle Pharmaceuticals Launches Free Trial of NITYR in the US and Partners With Cambrooke Therapeutics to Support HT-1 Patients’ Dietary Needs

Cycle Pharmaceuticals launches of a new program in the US to offer patients with hereditary tyrosinemia type 1 (HT-1) the opportunity to experience NITYR (nitisinone) tablets for free for three weeks.

November 13, 2017

·

3 min read

FDA

Allergan Receives FDA Approval for Use of VRAYLAR (cariprazine) in the Maintenance Treatment of Schizophrenia

The efficacy of VRAYLAR in the maintenance treatment of schizophrenia was based on an up to 72-week, multinational, double-blind, placebo-controlled, randomized withdrawal study in the prevention of relapse in adult patients with schizophrenia.

November 13, 2017

·

12 min read